Article
Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH-mutant and 1p/19q-codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report.
Neuropathology and applied neurobiology - 1 Feb 2023
Ehret Felix, Hansch Alexander, Meinhardt Jenny, Hain Elisabeth Gertrud, Misch Martin, Onken Julia, Roohani Siyer, Koch Arend, Schweizer Leonille, Radke Josefine, Kaul David
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.